What are the key issues in Competitive Intelligence and Competitor Insights in pharma industry in the US?
This was selected as Best Answer Probably more energy is applied to understanding competitors’ pipelines than anything else. The therapeutic focus, products in development, and clinical profile of those products helps companies forecast the future competitive landscape for their portfolio of launched products and development candidates. Particularly important are new mechanisms of action being exploited for high value applications. Fast followers try to put candidates also operating by the same mechanism into development as soon as possible. A second key issue is acquisition and partnering strategies. Key innovations often attract the attention of most or all pharma companies and lest any be left out of the market, each seeks a way to lock in a piece of the opportunity. The rush to acquire or partner with siRNA companies over the last two years is a good example of many big pharma companies seeking to lock in IP for what may (or may not) become an important pharmaceutical platform in t
